GAGLIARDI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 2.200
AS - Asia 1.847
EU - Europa 873
SA - Sud America 336
AF - Africa 45
OC - Oceania 14
Totale 5.315
Nazione #
US - Stati Uniti d'America 2.101
SG - Singapore 780
IT - Italia 299
CN - Cina 294
BR - Brasile 265
VN - Vietnam 252
HK - Hong Kong 174
DE - Germania 159
GB - Regno Unito 72
ID - Indonesia 65
IN - India 63
JP - Giappone 63
FR - Francia 49
MX - Messico 44
CA - Canada 42
FI - Finlandia 42
PL - Polonia 42
NL - Olanda 40
RU - Federazione Russa 39
AR - Argentina 35
BD - Bangladesh 22
TR - Turchia 21
SE - Svezia 19
ES - Italia 18
ZA - Sudafrica 17
IQ - Iraq 16
AT - Austria 15
AU - Australia 14
UA - Ucraina 12
AE - Emirati Arabi Uniti 11
PK - Pakistan 11
CO - Colombia 9
EC - Ecuador 9
SA - Arabia Saudita 9
MY - Malesia 8
PH - Filippine 8
CH - Svizzera 7
LT - Lituania 7
MA - Marocco 7
RO - Romania 7
CZ - Repubblica Ceca 6
EG - Egitto 6
IE - Irlanda 6
CR - Costa Rica 5
GR - Grecia 5
KR - Corea 5
TH - Thailandia 5
VE - Venezuela 5
BE - Belgio 4
DK - Danimarca 4
HU - Ungheria 4
NG - Nigeria 4
UY - Uruguay 4
BH - Bahrain 3
CL - Cile 3
DO - Repubblica Dominicana 3
KE - Kenya 3
KG - Kirghizistan 3
PY - Paraguay 3
TW - Taiwan 3
UZ - Uzbekistan 3
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
IR - Iran 2
JO - Giordania 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BW - Botswana 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
Totale 5.309
Città #
Singapore 492
Ashburn 410
San Jose 217
Hong Kong 169
Santa Clara 164
Chandler 127
Dallas 106
Beijing 95
Ho Chi Minh City 87
Munich 85
Los Angeles 76
Council Bluffs 75
New York 63
Tokyo 61
Hanoi 60
Jakarta 53
Milan 50
Fairfield 45
Warsaw 41
Lauterbourg 36
Shanghai 35
São Paulo 33
Ferrara 32
Mexico City 28
Houston 27
Addison 23
Bologna 23
Chicago 23
London 22
Bremen 21
Chennai 21
Princeton 21
Rome 20
Denver 18
Helsinki 18
Toronto 18
Hefei 17
Orem 17
Atlanta 15
Seattle 15
The Dalles 15
Cambridge 14
Turku 14
Phoenix 13
San Francisco 13
Amsterdam 12
Frankfurt am Main 12
Manchester 12
Wilmington 12
Buffalo 11
Modena 11
Montreal 11
San Diego 11
Brooklyn 10
Stockholm 10
Boston 9
Da Nang 9
Haiphong 9
Lappeenranta 9
New Delhi 9
Rio de Janeiro 9
Woodbridge 9
Falkenstein 8
Moscow 8
Poplar 8
Sydney 8
Ann Arbor 7
Boardman 7
Casalecchio Di Reno 7
Hải Dương 7
Mumbai 7
Ankara 6
Baghdad 6
Charlotte 6
Kuala Lumpur 6
Brasília 5
Buenos Aires 5
Guarulhos 5
Hillsboro 5
Johannesburg 5
Nuremberg 5
Ottawa 5
Paris 5
Portland 5
Salt Lake City 5
Thái Nguyên 5
Vienna 5
Washington 5
Assago 4
Barnet 4
Brno 4
Bến Tre 4
Cairo 4
Campinas 4
Casablanca 4
Columbus 4
Dhaka 4
Dublin 4
Florence 4
Jamaica Plain 4
Totale 3.407
Nome #
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 197
A tool to predict survival in stage IV entero-pancreatic NEN 184
Challenges in metastatic gastroenteropancreatic neuroendocrine neoplasms (GEPNENs) in well differentiated G1 primitive tumors 179
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review 167
Functional hypothalamic and drug-induced amenorrhea: an overview 166
Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients 163
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 161
Evaluation of new prognostic tools for neuroendocrine tumors: from clinical scores to genetic profiling 161
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 153
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome 153
Acromegaly in the elderly patients 151
Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult 147
Communicating the diagnosis of Klinefelter syndrome to children and adolescents: when, how, and who? 144
GH/IGF-1 axis in a large cohort of ss-thalassemia major adult patients: a cross-sectional study 142
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review 137
The role of opportunistic quantitative computed tomography in the evaluation of bone disease and risk of fracture in thalassemia major 136
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter? 135
Bone health in adolescence 134
Craniopharyngioma and Eating Disorders 131
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study 129
Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment 129
NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids 129
Long-term low-dose tolvaptan efficacy and safety in SIADH 126
Bariatric Surgery in a Case of Hypopituitary Patient with Craniopharyngioma: Management of Hypopituitarism and Long-Term Efficacy 123
Iperprolattinemia: vecchie e nuove insidie diagnostiche 121
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 120
Hypeprolactinemia: still an insidious diagnosis 119
Correction to: Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget (Endocrine, (2022), 75, 1, (306-308), 10.1007/s12020-021-02896-7) 118
Malattia di Cushing e adenoma ipofisario multiclonale: la strana coppia 107
Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget 106
Effetto del diabete sulla morbilità e mortalità in pazienti con acromegalia 104
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 101
Cholecalciferol use is associated with a decreased risk of incident morphometric vertebral fractures in acromegaly 98
Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot Study 97
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 89
Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line 88
I livelli di colesterolo LDL sono associati alla secrezione insulinica 88
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance 80
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience 72
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 71
L’acromegalia nell’anziano 68
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4) 66
Valutazione dell’efficacia della terapia transdermica e iniettiva con testosterone nella Sindrome di Klinefelter: uno studio in real-life 63
Marcatori prognostici nelle neoplasie neuroendocrine (NEN) [Neuroendocrine Neoplasms prognostic markers] 55
Acromegalia: differenze di sesso e genere [Sex and gender differences in acromegaly] 40
Totale 5.448
Categoria #
all - tutte 29.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 787
Totale 30.111


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 18 8 7
2021/2022166 9 4 1 2 11 10 8 16 6 6 8 85
2022/2023309 23 56 15 32 34 26 38 30 26 4 19 6
2023/2024314 12 24 15 10 16 47 13 27 26 15 15 94
2024/20251.264 43 50 96 52 138 138 60 54 217 118 162 136
2025/20263.266 348 131 319 418 554 226 408 229 298 335 0 0
Totale 5.448